Trends in the incidence of childhood type 1 diabetes after the COVID-19 lockdown in Finland: An observational study
Open Access
- 2 November 2026
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 23 (11) , e1005288
Abstract
Background: While COVID-19 lockdowns have been systematically associated with increased incidence rate of type 1 diabetes, less is known about the disease rates after lockdowns. We compared the incidence of type 1 diabetes after the COVID-19 pandemic-related closure of society (i) to the time when lockdown was implemented and to (ii) the time before the pandemic in Finland. Methods and findings: The incidence of type 1 diabetes after the lockdown (09/2021–12/2022) was compared to the incidence during the lockdown (03/2020–08/2021) and before the lockdown (three 18-month terms 2014–2019) in Finnish children under the age of 15 years. Previous exposure to SARS-CoV-2 was identified by combining information on COVID-19 vaccination with data on SARS-CoV-2 antibodies analyzed in blood samples. The temporal cohort included 3,467 pediatric type 1 diabetes cases, distributed across post-lockdown ( n = 586), lockdown ( n = 785), and pre-pandemic ( n = 2,096) periods. The incidence of type 1 diabetes after the lockdown was significantly lower than the incidence during the lockdown [incidence rate ratio (IRR = 0.85; 95% Cl [0.77,0.95]; p = 0.004)]. The rate of type 1 diabetes after the lockdown did not significantly differ from the time before lockdown (IRR = 1.00; 95% Cl [0.91,1.09]; p = 0.932). The frequency of children testing positive for infection-associated SARS-CoV-2 antibodies increased from 0.9% during the lockdown to more than 40% after the lockdown. Study limitations include a relatively short follow-up period after the lockdown and the lack of explicit modeling of the underlying long-term secular trend in type 1 diabetes incidence. Conclusions: The lockdown represents a peak in childhood type 1 diabetes incidence in Finland compared to both the pre-pandemic and post-lockdown periods. However, the reversion toward historical levels after the lockdown does not necessarily establish a return to the expected historical trajectory, nor can it fully distinguish a transient change from temporal compensation superimposed on the background secular trend. The contrasting patterns between type 1 diabetes incidence and SARS-CoV-2 antibody prevalence during and after the lockdown suggest an indirect rather than a direct role of the virus in triggering the observed changes in incidence.Keywords
Funding Information
- Helsingin ja Uudenmaan Sairaanhoitopiiri (TYH 2021316)
- Helsingin ja Uudenmaan Sairaanhoitopiiri (TYH2021343)
- Horizon 2020 Framework Programme (874735)
- Academy of Finland (350455)
- Academy of Finland (308613)
- Academy of Finland (351040)
- EU HERA: DURABLE (101102733)
- Jane ja Aatos Erkon Säätiö (20242044)
- VTR (TYH2025391)
- Sigrid Juséliuksen Säätiö
- Medicinska Understödsföreningen Liv och Hälsa
- Doctoral School of the University of Helsinki
- Lastentautien Tutkimussäätiö
- the Bjorkqvist Foundation
- Helsinki University Library
This publication has 35 references indexed in Scilit:
- SARS-CoV-2 and diabetes: a post-pandemic reappraisalDiabetologia, 2026
- Trends in type 1 diabetes incidence between 2007 and 2023 and their association with SARS-CoV-2 infection in a population-based matched cohort study among individuals under 30 years old in SwedenDiabetologia, 2025
- Higher population density protects from type 1 diabetes? Dissecting the literature through meta-analysisDiabetes Research and Clinical Practice, 2025
- Progression From Presymptomatic to Clinical Type 1 Diabetes After COVID-19 InfectionJAMA, 2024
- Infection episodes and islet autoantibodies in children at increased risk for type 1 diabetes before and during the COVID-19 pandemicInfection, 2024
- SARS-CoV-2 Infection and Development of Islet Autoimmunity in Early ChildhoodJAMA, 2023
- Image-based and machine learning-guided multiplexed serology test for SARS-CoV-2Cell Reports Methods, 2023
- Incidence of Diabetes in Children and Adolescents During the COVID-19 PandemicJAMA Network Open, 2023
- Impact of the first COVID-19 lockdown on body weight: A combined systematic review and a meta-analysisClinical Nutrition, 2022
- The risk of progression to type 1 diabetes is highly variable in individuals with multiple autoantibodies following screeningDiabetologia, 2019